Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Joseph

Showing results (521-530 of 547) with videos related to

Pageof 55
Sort By:
The Science of the Total Environment|July 10, 2017
Pyrolysis of attapulgite clay blended with yak dung enhances pasture growth and soil health: Characterization and initial field trialsMuhammad Khalid Rafiq, Stephen D Joseph, Fei Li, et al.
Journal of Medicinal Chemistry|August 9, 2018
Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast CancerJohnny Nagasawa, Steven Govek, Mehmet Kahraman, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927Mehmet Kahraman, Steven P Govek, Johnny Y Nagasawa, et al.
Breast Cancer Research : BCR|June 29, 2019
Gene expression signature of atypical breast hyperplasia and regulation by SFRP1Kelly J Gregory, Amy L Roberts, Erin M Conlon, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2015
Optimization of an indazole series of selective estrogen receptor degraders: Tumor regression in a tamoxifen-resistant breast cancer xenograftSteven P Govek, Johnny Y Nagasawa, Karensa L Douglas, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2008
Pyrazinoindolone inhibitors of MAPKAP-K2D R Goldberg, Y Choi, D Cogan, et al.
Journal of Medicinal Chemistry|April 17, 2015
Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer XenograftsAndiliy Lai, Mehmet Kahraman, Steven Govek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2020
Regional Emergence of Candida auris in Chicago and Lessons Learned From Intensive Follow-up at 1 Ventilator-Capable Skilled Nursing FacilityMassimo Pacilli, Janna L Kerins, Whitney J Clegg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 18, 2021
Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020James T Lee, Elisabeth M Hesse, Heather N Paulin, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2018
Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograftSteven P Govek, Celine Bonnefous, Jackaline D Julien, et al.
Pageof 55

Showing results (521-530 of 547) with videos related to

Sort By:
Pageof 55
The Science of the Total Environment|July 10, 2017
Pyrolysis of attapulgite clay blended with yak dung enhances pasture growth and soil health: Characterization and initial field trialsMuhammad Khalid Rafiq, Stephen D Joseph, Fei Li, et al.
Journal of Medicinal Chemistry|August 9, 2018
Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast CancerJohnny Nagasawa, Steven Govek, Mehmet Kahraman, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927Mehmet Kahraman, Steven P Govek, Johnny Y Nagasawa, et al.
Breast Cancer Research : BCR|June 29, 2019
Gene expression signature of atypical breast hyperplasia and regulation by SFRP1Kelly J Gregory, Amy L Roberts, Erin M Conlon, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2015
Optimization of an indazole series of selective estrogen receptor degraders: Tumor regression in a tamoxifen-resistant breast cancer xenograftSteven P Govek, Johnny Y Nagasawa, Karensa L Douglas, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2008
Pyrazinoindolone inhibitors of MAPKAP-K2D R Goldberg, Y Choi, D Cogan, et al.
Journal of Medicinal Chemistry|April 17, 2015
Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer XenograftsAndiliy Lai, Mehmet Kahraman, Steven Govek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2020
Regional Emergence of Candida auris in Chicago and Lessons Learned From Intensive Follow-up at 1 Ventilator-Capable Skilled Nursing FacilityMassimo Pacilli, Janna L Kerins, Whitney J Clegg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 18, 2021
Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020James T Lee, Elisabeth M Hesse, Heather N Paulin, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2018
Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograftSteven P Govek, Celine Bonnefous, Jackaline D Julien, et al.
Pageof 55